Systematic review of antidepressant therapies in Parkinson's disease

Lookup NU author(s): Dr Katherine Deane

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Depression is the most common psychiatric disturbance in Parkinson's disease. We conducted a Cochrane systematic review to assess the efficacy and safety of antidepressant therapies in idiopathic Parkinson's disease. Relevant trials were identified from electronic databases, reference lists and queries to antidepressant manufacturers. Three randomised controlled trials examined oral antidepressants in 106 patients with Parkinson's disease. No eligible trials of electroconvulsive or behavioural therapy were found. In the first arm of the crossover trial by Andersen et al. (n=22), nortriptyline treated patients showed a larger improvement than placebo in a unique depression rating scale after 16 weeks although significance levels were not provided. A parallel group trial by Wermuth et al. (n=37) did not show any significant difference between citalopram and placebo in Hamilton score after 52 weeks. Rabey et al. (n=47) performed an open-label trial comparing fluvoxamine with amitriptyline. Similar numbers in each group had a 50% reduction in Hamilton score after 16 months. Major side effects including visual hallucinations and confusion were reported with fluvoxamine and amitriptyline. Insufficient data on the effectiveness and safety of antidepressant therapies in Parkinson's disease are available on which to make recommendations for their use. Large scale randomised controlled trials are urgently required. [References: 59]

Publication metadata

Author(s): Deane KHO; Chung TH; Ghazi-Noori S; Rickards H; Clarke CE

Publication type: Article

Publication status: Published

Journal: Parkinsonism & Related Disorders

Year: 2003

Volume: 10

Issue: 2

Pages: 59-65

ISSN (print): 1353-8020

ISSN (electronic): 1873-5126

Publisher: Elsevier Ltd

URL: (03)00108-1

DOI: 10.1016/S1353-8020(03)00108-1

Notes: Chung TH Deane KH Ghazi-Noori S Rickards H Clarke CE Review England Journal Article Review

Altmetrics

Share